M16
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - Presence of the signed consent form - Patients suffering from osteoarthritis of the hip joint for which a total hip replacement has been medically indicated. - Patients who are cognitively and linguistically able to read and understand the information of the study and its questions. - Patients suffering from moderate to severe symptoms originating from the affected hip (min. VAS = 4) - Patients with an age of more than 18 years
Exclusion criteria
Exclusion criteria: - Failure to meet inclusion criteria - Patient refusal - Incapacity of the patient to give consent - Insufficient knowledge of German, or insufficient understanding of the study - Lack of medical indication for implantation of total hip arthroplasty - History of infection of the leg to be operated on - Previous surgery on the affected leg within the last 6 months - Presence of rheumatoid arthritis - Current tumor therapy or tumor disease - Current deep vein thrombosis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Endpoint of the volunteer: 3 laboratory tests, which are determined. Laboratory testing of D-dimers: 1st preoperatively (admission laboratory). 2. on the 1st postoperative day (routine laboratory post-op) 3. on postoperative day 5-8 or before discharge. Study Objective: 75 subjects per arm | — |
Countries
Germany
Contacts
Uniklinik Köln